| Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cripto | cis | Discovery | rs3806701 | 3:46,617,337 | G/A | 0.27 | 997 | 1.106 | 0.036 | 3.8×10-145 | 1.230 | 3.7×10-84 | 2.8×10-28 |
| Cripto | cis | Replication | rs3806702 | 3:46,617,502 | A/G | 0.22 | 337 | 1.050 | 0.070 | 3.3×10-39 | 1.210 | 1×10-32 | 1.2×10-20 |
| Target (abbrv.) | Cripto |
| Target (full name) | Teratocarcinoma-derived growth factor 1 |
| Somalogic ID (Sequence ID) | SL005155 (2672-60_1) |
| Entrez Gene Symbol | TDGF1 |
| UniProt ID | P13385 |
| UniProt Comment |
|
| Biomarker applications (based on IPA annotation) |
|
All locus annotations are based on the sentinel SNP (rs3806701) and 8 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
| Genes hit or close-by |
|
| Potentially regulated genes | |
| eQTL genes |
| Trait | P | Study | Source |
|---|---|---|---|
| cg00285902 (chr3:46605640) | 8.8×10-35 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
| P13385 protein abundance levels | 7.1×10-13 | 22595970 (PMID) | GRASP2 pQTL |
| Gene expression of LRRC2 (probeID ILMN_1755047) in cerebellum in Alzheimer's disease cases and controls | 5.3×10-12 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of LRRC2 (probeID ILMN_1755047) in cerebellum in Alzheimer's disease cases | 9.2×10-7 | 22685416 (PMID) | GRASP2 eQTL |
| Gene expression of LRRC2 (probeID ILMN_1755047) in cerebellum in non-Alzheimer's disease samples | 2.1×10-6 | 22685416 (PMID) | GRASP2 eQTL |